Traphagen Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,480
| Closed | -$202K | – | 176 |
|
|
2023
Q3 | $202K | Buy |
3,480
+230
| +7% | +$13.4K | 0.03% | 155 |
|
|
2023
Q2 | $208K | Buy |
3,250
+13
| +0.4% | +$831 | 0.03% | 149 |
|
|
2023
Q1 | $224K | Buy |
3,237
+12
| +0.4% | +$832 | 0.03% | 141 |
|
|
2022
Q4 | $232K | Buy |
3,225
+123
| +4% | +$8.85K | 0.04% | 136 |
|
|
2022
Q3 | $221K | Buy |
3,102
+10
| +0.3% | +$711 | 0.04% | 127 |
|
|
2022
Q2 | $238K | Buy |
3,092
+56
| +2% | +$4.31K | 0.04% | 122 |
|
|
2022
Q1 | $222K | Buy |
3,036
+1,796
| +145% | +$131K | 0.04% | 128 |
|
|
2021
Q4 | $227K | Hold |
1,240
| – | – | 0.04% | 127 |
|
|
2021
Q3 | $207K | Hold |
1,240
| – | – | 0.04% | 131 |
|
|
2021
Q2 | $200K | Sell |
1,240
-2,673
| -68% | -$432K | 0.03% | 136 |
|
|
2021
Q1 | $247K | Buy |
3,913
+88
| +2% | +$5.56K | 0.05% | 119 |
|
|
2020
Q4 | $237K | Sell |
3,825
-87
| -2% | -$5.4K | 0.04% | 118 |
|
|
2020
Q3 | $236K | Sell |
3,912
-138
| -3% | -$8.32K | 0.05% | 108 |
|
|
2020
Q2 | $238K | Sell |
4,050
-47
| -1% | -$2.76K | 0.05% | 108 |
|
|
2020
Q1 | $228K | Buy |
+4,097
| New | +$228K | 0.06% | 105 |
|